Tongue Ultrasonography in the Screening of Severe Obstructive Sleep Apnea Syndrome—Promising Potential for Overloaded Sleep Centers
2024

Using Tongue Ultrasound to Screen for Severe Sleep Apnea

Sample size: 64 publication 10 minutes Evidence: moderate

Author Information

Author(s): Smiesko Milan, Jenigarova Ester, Stanko Peter, Kasa Zsolt, Cavarga Ivan, Lassan Stefan

Primary Institution: Department of Pneumology, Phthisiology and Functional Diagnostics, Slovak Medical University and Bratislava University Hospital

Hypothesis

Can tongue ultrasonography be used as an effective screening tool for severe obstructive sleep apnea syndrome (OSAS)?

Conclusion

Tongue ultrasonography, particularly measuring tongue base thickness and distance between lingual arteries, shows promise as an effective screening tool for identifying severe OSAS.

Supporting Evidence

  • A TBT threshold of ≥65 mm had a sensitivity of 74.4% and specificity of 61.9%.
  • A DLA threshold of ≥30 mm showed a sensitivity of 69.8% and specificity of 71.1%.
  • The overall accuracy of TBT and DLA measurements was 70.3% in identifying severe OSAS.
  • Patients with severe OSAS had significantly higher TBT and DLA values compared to those without OSAS.
  • The Q-OSAS questionnaire was positive in 74.4% of patients with severe OSAS.

Takeaway

Doctors can use a special ultrasound to look at the tongue to help find out if someone has a serious sleep problem called obstructive sleep apnea.

Methodology

The study involved a cross-sectional diagnostic design where 64 patients underwent tongue ultrasonography to measure tongue base thickness and distance between lingual arteries, which were then correlated with apnea-hypopnea index values from polysomnography.

Potential Biases

Potential for inaccurate self-reporting by patients, especially among professional drivers concerned about their health status.

Limitations

Prior tongue surgery could affect the measured parameters, and the Q-OSAS questionnaire's performance may be influenced by the setting in which it was administered.

Participant Demographics

The study included 64 participants (43 men, 21 women) aged 26 to 77 years, with an average age of 53.

Statistical Information

P-Value

0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/diseases12120330

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication